ALKBH5 and plasma cell myeloma: Silencing ALKBH5 suppresses the proliferation of patient-derived GSCs.35 Furthermore, ALKBH5 is found to be required for the development and maintenance of AML and self-renewal of leukemia stem/initiating cells.13 Similarly, precise stem cell surface marker is lacked in multiple myeloma.